In recent days, the news has been filled with reports of yet another virus that seems to be spreading enthusiastically around the world. Several cases of monkey pox were identified this week in England, Spain, Portugal and now Belgium. The second case of the virus was diagnosed at UZ Leuven last night. However, the Danish pharmaceutical producer, Bavarian Nordic, has an effective vaccine that sent the company’s stock skyrocketing on Friday morning.
News of the monkey pox outbreak has increased significantly in recent days. The virus normally occurs mainly in Africa, but now several infections have been identified in Europe and also Belgium. Visit Ipostocksplanner.com for more information. A second case was confirmed in Belgium on Thursday night, virologist Marc Van Ranst said. For the time being, this is still a rare outbreak of the disease.
A second case of monkeypox virus was diagnosed last night at our lab in Leuven in a sample from a man from Flemish Brabant.
People who recognize injuries such as the one in this photo should contact their doctor.
In response to the news, the share of the Danish pharmaceutical group Bavarian Nordic has been on the rise since Thursday. The pharmaceutical company claims to be the only producer in the world that has succeeded in obtaining approval for a vaccine against monkeypox.
Response to dissemination
In response to the spread of the virus, the United States has placed an order for $119 million with the company after an initial infection was found in a man in Massachusetts. Specifically, it concerns the Jynneos vaccine, which is used for the prevention of smallpox and monkeypox. The first doses should be delivered by 2024. On Friday morning, the company’s stock climbed nearly 24 percent to its all-time high.
“We are pleased to announce the exercise of our contract with the US government for a freeze-dried version of the smallpox vaccine. It will be delivered to our new filling and finishing facility in the country. This is an important milestone in our partnership with the US,” said Paul Chaplin, CEO of Bavarian Nordic in a statement.
Monkeypox is a viral disease that was first discovered in 1958 in colonies of monkeys kept for research. The first human case was recorded in 1970. Symptoms include fever, headache, swollen lymph nodes, chills and exhaustion. Within days, a rash develops over the person’s body. The death rate is roughly 0 to 10 percent and slightly higher in children.
In total, there are 44 confirmed infections worldwide and no deaths yet.